Indeed, one study demonstrated that overweight ovarian cancer patients who exhibit higher levels of leptin as well as ObR expression in serum and ascites isolated from metastatic patients demonstrate worse overall survival (OS) [192]. This evidence concerns the gene LEPR and ovarian carcinoma.